openPR Logo
Press release

Bronchopulmonary Dysplasia (BPD) Patient Pool Analysis Market to Reach USD 593.4 Million by 2034

12-08-2025 05:53 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Bronchopulmonary Dysplasia (BPD) Patient Pool Analysis

Bronchopulmonary Dysplasia (BPD) Patient Pool Analysis

Pune, India - December 2025 - The global Bronchopulmonary Dysplasia Patient Pool Analysis Market, valued at USD 331.2 million in 2024, is projected to reach USD 593.4 million by 2034, growing at a 6.1% CAGR (2025-2034), according to Exactitude Consultancy. Rising global preterm births, improved survival rates of extremely low birth weight infants, and enhanced neonatal intensive care capabilities are driving the demand for accurate BPD epidemiology and patient pool assessment.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72124

Market Summary
The Bronchopulmonary Dysplasia (BPD) Patient Pool Analysis Market is expanding as healthcare systems focus on quantifying disease burden among premature infants requiring prolonged respiratory support. BPD remains one of the most common chronic lung diseases in neonates, particularly those born before 28 weeks of gestation. Improvements in NICU technologies, ventilation strategies, surfactant therapy, antenatal steroids, and overall neonatal survival have unintentionally increased the number of infants living with moderate to severe BPD. As a result, the need for granular patient pool modeling-incidence, prevalence, severity grading, comorbidities, and long-term outcomes-is accelerating across global clinical and research settings.

The demand for patient pool analysis is also rising due to ongoing clinical trials assessing stem cell therapies, growth factors, non-invasive ventilation methods, and novel pulmonary drugs. Countries in Asia-Pacific and Africa, which record the highest preterm birth rates, are witnessing rapid growth in reported BPD cases as neonatal care infrastructure improves. Meanwhile, North America and Europe maintain the largest documented BPD patient databases due to advanced surveillance systems and research registries. Accurate population modeling is becoming essential for healthcare planning, market sizing for emerging therapies, and optimizing neonatal care strategies.

Key Takeaways
• 2024 Market Size: USD 331.2 Million
• 2034 Forecast: USD 593.4 Million
• CAGR: 6.1% (2025-2034)
• Rising preterm births expanding the global BPD patient pool
• Advanced NICUs improving survival of extremely premature infants
• Asia-Pacific shows highest growth due to rising neonatal care modernization

Market Drivers
• Increasing global burden of preterm births (15+ million annually)
• Improved survival of low birth weight & critically ill neonates
• Growing adoption of advanced neonatal respiratory support systems
• Expansion of neonatal screening & BPD severity grading tools
• Rising clinical trials for regenerative and anti-inflammatory therapies

Segmentation Snapshot
By Patient Type / Severity
• Mild BPD
• Moderate BPD
• Severe BPD
• Extremely Preterm & ELBW Infants

By Data Source
• Hospital NICU Databases
• National Neonatal Registries
• Insurance & Claims Databases
• Research Cohorts & Clinical Trials

By End User
• Hospitals
• Research Institutes
• Government Healthcare Agencies
• Pharmaceutical & Biotech Companies
• CROs & Epidemiology Service Providers

By Region
• North America (Largest Patient Database)
• Europe
• Asia-Pacific (Fastest Growing Patient Pool)
• Latin America
• Middle East & Africa

Explore Full Report here: https://exactitudeconsultancy.com/reports/72124/bronchopulmonary-dysplasia-patient-pool-analysis-market

Recent Developments
• Increased publication of BPD patient registries supporting AI-based epidemiology modeling.
• Rapid adoption of non-invasive ventilation reducing severe BPD progression.
• New regenerative therapies entering Phase I/II clinical trials for BPD.

Expert Quote - Irfan Tamboli, Business Development Executive
"The rise in preterm births and improved neonatal survival have expanded the global BPD patient pool significantly. Accurate epidemiological modeling is now essential for planning new therapies, NICU investments, and global healthcare strategies."

Conclusion
The Bronchopulmonary Dysplasia Patient Pool Analysis Market will continue growing through 2034 as global healthcare systems invest in advanced neonatal care, epidemiology research, and emerging BPD therapies. Organizations leveraging comprehensive patient pool analytics, real-world data, and predictive epidemiology tools will lead strategic decision-making over the next decade.

This report is also available in the following languages : Japanese (気管支肺異形成症患者プール分析、市場), Korean (기관지폐이형성증 환자 풀 분석, 시장), Chinese (支气管肺发育不良患者群体分析,市场), French (Analyse du marché des patients atteints de dysplasie bronchopulmonaire), German (Analyse des Patientenpools für bronchopulmonale Dysplasie, Markt), and Italian (Analisi del pool di pazienti con displasia broncopolmonare, mercato), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/72124

Related Reports

Dyspnea Market
https://exactitudeconsultancy.com/reports/71492/dyspnea-market

Chronic Obstructive Pulmonary Disease (COPD) Patient Pool Analysis Market
https://exactitudeconsultancy.com/reports/71519/chronic-obstructive-pulmonary-disease-copd-patient-pool-analysis-market

Allergic Bronchopulmonary Aspergillosis Market
https://exactitudeconsultancy.com/reports/71757/allergic-bronchopulmonary-aspergillosis-market

Chronic Pulmonary Infections Market
https://exactitudeconsultancy.com/reports/71955/chronic-pulmonary-infections-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bronchopulmonary Dysplasia (BPD) Patient Pool Analysis Market to Reach USD 593.4 Million by 2034 here

News-ID: 4304002 • Views:

More Releases from Exactitude Consultancy

Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epilepsy Prevalence & Breakthrough Anti-Seizure Therapies
Partial Seizure Market to Reach USD 11.24 Billion by 2034 Driven by Rising Epile …
Pune, India - December 2025 - The global Partial Seizure Market, valued at USD 6.82 billion in 2024, is projected to reach USD 11.24 billion by 2034, growing at a 5.2% CAGR (2025-2034), according to Exactitude Consultancy. Increasing global epilepsy burden, development of new anti-seizure medications (ASMs), and expanded access to neurological diagnostics are fueling strong market growth. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/72069 Market Summary The Partial Seizure Market
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Partial Epilepsy Market to Reach USD 9.36 Billion by 2034
Pune, India - December 2025 - The global Partial Epilepsy Market, valued at USD 5.84 billion in 2024, is projected to reach USD 9.36 billion by 2034, growing at a 4.8% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of focal (partial) seizures, development of improved anti-epileptic drugs (AEDs), and advancements in neuroimaging and neuromodulation therapies are key growth drivers. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/72067 Market Summary The Partial
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 19.42 Billion by 2034
Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market to Reach USD 1 …
Pune, India - December 2025 - The global Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market, valued at USD 6.84 billion in 2024, is projected to reach USD 19.42 billion by 2034, growing at a robust 11.0% CAGR (2025-2034), according to Exactitude Consultancy. Rapid advancements in AAV-based gene therapies, antisense oligonucleotides (ASOs), RNA-targeting technologies, and improved diagnostic pathways are driving strong market momentum. Download Full PDF Sample Copy of Market
Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Diabetes Risk & Digital Health Programs
Prediabetes Market to Reach USD 29.84 Billion by 2034 Driven by Rising Global Di …
Pune, India - December 2025 - The global Prediabetes Market, valued at USD 14.62 billion in 2024, is projected to reach USD 29.84 billion by 2034, growing at a 7.2% CAGR (2025-2034), according to Exactitude Consultancy. The rising prevalence of insulin resistance, sedentary lifestyles, obesity, and increased screening initiatives are fueling substantial market growth. Download Full PDF Sample Copy of Market Report https://exactitudeconsultancy.com/request-sample/72063 Market Summary The Prediabetes Market is expanding rapidly as healthcare

All 5 Releases


More Releases for BPD

Bronchopulmonary Dysplasia (BPD) Patient Pool Analysis and Market Forecast 2024- …
Introduction Bronchopulmonary dysplasia (BPD) is a chronic lung disease that primarily affects premature infants requiring prolonged mechanical ventilation or supplemental oxygen. It remains one of the most serious complications of preterm birth, with lasting effects on pulmonary function, growth, and neurodevelopment. The condition not only drives neonatal intensive care unit (NICU) costs but also increases long-term healthcare utilization for affected children. Growing global rates of preterm birth, along with improvements in neonatal
Bronchopulmonary Dysplasia (BPD) Epidemiology Market Analysis
Bronchopulmonary Dysplasia (BPD) represents one of the most significant complications of preterm birth, affecting the respiratory system of premature infants and creating substantial healthcare challenges worldwide. The BPD epidemiology market encompasses therapeutic interventions, diagnostic tools, and supportive care technologies designed to address this chronic lung disease affecting neonates. As medical advances continue to improve survival rates among extremely premature infants, the prevalence of BPD has correspondingly increased, driving demand for
Bearing Protection Device (BPD) Market | AESSEAL, Advanced Sealing International …
The global bearing protection device (bpd) market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the bearing protection device (bpd) market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving
Bipolar Disorder (BPD) Market Segmentation and Analysis Research Report to 2025
Bipolar disorder, commonly known as manic depression, is a type of mental illness which is characterized by mood swings. Mood episodes are of two types: manic and depressive episodes. The changes in the mental state bring out sudden high or low moods in a person. An individual suffering from bipolar disorder can be happy, joyful, and energized at a particular moment and can also be sad, hopeless, and sluggish at
Bipolar Disorder (BPD) Market Size & Share Analysis & Industry Outlook - 2025
Bipolar disorder, commonly known as manic depression, is a type of mental illness which is characterized by mood swings. Mood episodes are of two types: manic and depressive episodes. The changes in the mental state bring out sudden high or low moods in a person. An individual suffering from bipolar disorder can be happy, joyful, and energized at a particular moment and can also be sad, hopeless, and sluggish at
Bipolar Disorder (BPD) Market Research Report : : Technologies, Markets and Play …
Bipolar disorder, commonly known as manic depression, is a type of mental illness which is characterized by mood swings. Mood episodes are of two types: manic and depressive episodes. The changes in the mental state bring out sudden high or low moods in a person. An individual suffering from bipolar disorder can be happy, joyful, and energized at a particular moment and can also be sad, hopeless, and sluggish at